Xenopus laevis oocytes were micro'niected with low molecular weight phosphoesters such as 2-glycerophosphate, phosphotyrosine, phosphoserine, phosphothreonine, 4-nitrophenyl phosphate, and orthophosphate. These compounds were able to induce a considerable reduction in the time course of progesterone-induced maturation, with 2-glycerophosphate being the most effective. The basal level of cAMP and its drop during maturation were not affected by the microinjection of 2-glycerophosphate. The injection of alkaline phosphatase (EC 3.1.3.1.) from calf intestine at a low concentration (10 ng per oocyte) was able to decrease or abolish the effect of 2-glycerophosphate. At higher concentration (25 ng per oocyte) this enzyme totally blocked progesterone-or maturation-promoting factor-induced maturation. Alkaline phosphatase might behave in vivo as a phosphoprotein phosphatase active towards phosphotyrosine-containing proteins. In addition, our results indicate that phosphate or phosphoester-containing buffers should be avoided in the course of maturation-promoting factor purification.
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The maturation-promoting factor (MPF) was originally detected as an activity present in the cytoplasm of maturing amphibian oocytes-i.e., oocytes that are resuming the first meiotic cell division (reviewed in ref. 1) . When a small amount of mature cytoplasm (50 nl) is transferred into an immature diplotene-stage arrested oocyte, germinal vesicle (oocyte nucleus) breakdown (GVBD) is observed in <2-3 hr. When immature oocytes are treated with progesterone (1 ,4M), MPF activity is detectable shortly prior to the breakdown of the nuclear envelope. Although existence of MPF has been known for more than a decade, its biochemical nature has not yet been elucidated. MPF can be extracted from mature oocytes and stabilized by low molecular weight phosphate compounds such as 2-glycerophosphate in the presence of MgATP and EGTA (2) . It is a polypeptide since proteolytic digestion totally destroys its biological activity. On the other hand, a burst of cAMP-independent protein phosphorylation occurs in vivo when MPF activity becomes detectable in maturing oocytes (3) (4) (5) . Such indirect evidence suggest that MPF activity is linked to a phosphorylation/dephosphorylation cascade.
The mechanisms leading to the appearance of active MPF in the oocyte cytoplasm are poorly understood. Strong experimental evidence indicates that cAMP, the catalytic (C) and regulatory (R) subunits of the cAMP-dependent protein kinase, and protein phosphatase 1 play a major role in the formation of MPF after progesterone action. Maller and Krebs (6) have shown that microinjection of R subunit into oocytes provokes the breakdown of the nuclear envelope in the absence of hormonal stimulation, whereas the injection of C subunit inhibits or delays the appearance of MPF in progesterone-treated oocytes. These experiments were confirmed by microinjection of the pure heat-stable protein kinase inhibitor: it also induces the maturation in the absence of hormone (6, 7) . More recently, it was shown that the inhibitor 1 (8) and inhibitor 2 (9) of protein phosphatase 1 are able to inhibit the progesterone-induced maturation. It was therefore postulated that a putative phosphoprotein, substrate for both C subunit and protein phosphatase 1, must be dephosphorylated in order to induce the formation of active MPF (7, 8, 10) . The increase in protein phosphorylation associated with MPF activity can be clearly distinguished from cAMP-dependent protein phosphorylation (10, 11) . It is therefore of major importance to identify the protein kinases or phosphatases ( (14) ] oocytes were carefully selected under a dissecting microscope. Under these conditions, when defolliculated oocytes were kept at 16°C, they remained responsive to progesterone or MPF treatment for at least 3-4 days.
Oocyte Microinjection. Protein kinase inhibitor was prepared in 5 mM 2-morpholineethanesulfonic acid buffer (pH 7.0) containing albumin (1 mg/ml). Alkaline phosphatase was dialyzed for 18 hr against 5 mM Hepes buffer (pH 7.5) containing albumin (1 mg/ml) and diluted in the same buffer.
Each oocyte was microinjected at the equator level with =1/20 its volume-i.e., 50 nl in stage VI oocyte. Microinjected solutions yield intracellular concentrations diluted -1:10, assuming a diffusion compartment of about 0.5 ,ul. All experiments were performed 24 hr after oocytes preparation, unless otherwise indicated.
For the MPF microinjections, animal pole cytoplasm taken from oocytes matured in the presence of progesterone (1 ,uM) was microinjected into recipient oocytes (15 nl per oocyte), at the equator level.
Oocyte Maturation. The criterion for maturation was the appearance of a white maturation spot surrounded by a pigmented ring at the animal pole of the oocyte. GVBD was ascertained by the absence of the germinal vesicle determined by dissection of the oocyte after 5 min of fixation in 10% trichloroacetic acid.
For cytological analysis, oocytes were fixed in Smith's solution, dehydrated, and embedded in paraffin. Serial sections (7-10 ,uM) were stained with Feulgen reagent/light green.
cAMP Determination. Usually 4 oocytes were manually homogenized quickly in 500 ul of boiling sodium acetate buffer (50 mM, pH 4) containing 1 mM theophylline. The tubes were spun in a vortex, boiled for 4 min, and then centrifuged at 4°C (24,000 x g, 15 min). The supernatant was used for the cAMP assay. The cAMP content of the extracts was determined by a binding assay method (15) . All buffers contained theophylline (1 mM). A standard curve for cAMP was used for each assay (0.2-5 pmol). All of the experimental points were assayed in duplicate and the values reported are the mean of duplicate determinations on oocytes from the same females.
RESULTS
2-Glycerophosphate Shortens the Kinetics of Oocyte Maturation. Oocytes were microinjected with 50 nl of a 50 mM solution of 2-glycerophosphate in distilled water adjusted to pH 7.5. They were treated 0, 30, 60, and 120 min later with progesterone (1 ,tM). In all cases, the times necessary to obtain 50% GVBD (GVBD 50) were shortened as compared to the uninjected control oocytes; a 60-min preincubation period was sufficient to obtain an optimal response (Fig. 1A) .
The same effect was observed when 48 hr-cultured oocytes were microinjected with 50 mM 2-glycerophosphate (Fig.  1B) . Microinjection of 50 nl of NaCl (100 mM) solution had no effect. When 2-glycerophosphate solutions in Tris, 2-morpholineethanesulfonic acid, and Hepes buffer (5 mM) were used, the kinetics of maturation were again shortened in a similar manner. The maximal advance for GVBD 50 was obtained when the pH was adjusted in the range of pH 7.5-8. The addition of bovine serum albumin (1 mg/ml) to the 2-glycerophosphate solution did not significantly modify the kinetics of maturation. These experiments were repeated by using oocytes of >16 different females. In all instances, the microinjection of 2-glycerophosphate accelerated the progress of progesterone-induced maturation. As shown in Fig. 1 Inset, 2-glycerophosphate is more efficient on slowly maturing oocytes than on rapidly maturing oocytes. The effect of 2-glycerophosphate is dose-dependent (Fig. 2) . A cytological analysis was performed on 2-glycerophosphate-and progesterone-treated oocytes. It showed that the breakdown of the germinal vesicle and the condensation of the chromosomes had occurred normally. Furthermore, 2 hr after the forma- The kinetics of in vivo MPF appearance were investigated in control and 2-glycerophosphate-injected oocytes. MPF activity appears more rapidly in 2-glycerophosphate-injected oocytes than in control oocytes (Fig. 3) .
When 2-glycerophosphate (25-50 mM) was added to the incubation medium, the kinetics of maturation were also shortened. However, in contrast to microinjection experiments, the response was variable among the different tested females.
Since Mg2l ions (10 mM) maturation were similar to those of progesterone (unpublished data).
The possibility that 2-glycerophosphate directly or indirectly modifies the cAMP level in the oocytes was tested. The basal level of cAMP was identical to 2-glycerophosphate-treated and control oocytes. In a typical experiment, the cAMP content was 1.4 pmol per oocyte in untreated oocytes versus 1.5 and 1.7 pmol per oocyte 1 and 2 hr, respectively, after 2-glycerophosphate microinjection. The drop in the level of cAMP induced by progesterone was similar in 2-glycerophosphate-treated and in control oocytes ( Table 1) .
The dose-response curve of maturation induced by the purified inhibitor of cAMP-dependent protein kinase was not modified in 2-glycerophosphate-microinjected oocytes (data not shown).
Altogether these experimental results indicate that 2-glycerophosphate does not modify the decrease in the activity of the endogenous catalytic subunit of cAMP-dependent protein kinase that is necessary to induce maturation (10) . Therefore, a cAMP-dependent phosphorylation does not seem to be involved in the action of 2-glycerophosphate.
Specificity of the 2-Glycerophosphate Action. How can we explain the 2-glycerophosphate action? At least two possibilities may account for its effect on maturation.
(i) 2-Glycerophosphate might act as a precursor of glycerol and 1-glycerophosphate and modify the concentration of some key intermediate metabolites. This possibility was ruled out by microinjecting either glycerol (50 mM) or 1-glycerophosphate (50 mM). The kinetics of progesterone-induced maturation were not modified by these compounds.
(ii) 2-Glycerophosphate might inhibit an endogenous phosphatase. To test this possibility, different low molecular weight phosphate esters (17) and NaF, known to inhibit phosphatases in vitro, were microinjected at the same concentration (25 mM). Except for F-ions, they all were efficient in decreasing the ratio: time for GVBD 50 in injected oocytes as compared to control oocytes (Fig. 4) . 2-Glycerophosphate was found to be the most efficient, followed by phosphotyrosine > phosphoserine, phosphothreonine > 4-nitrophenyl phosphate > orthophosphate. Similar results were obtained in three different experiments.
Alkaline Phosphatase Inhibits the Action of 2-Glycerophosphate and Blocks Progesterone-and MPF-Induced Maturation. When 2-glycerophosphate (50 mM) and alkaline phosphatase (10 ng or 2 ,uM solution) were injected together or injected successively into oocytes, the effect of 2-glycerophosphate on the kinetics of maturation was partially abolished (Fig. 5) .
Alkaline phosphatase was microinjected alone 1 hr before progesterone stimulation. Under these conditions, the enzyme injection was found to inhibit maturation. As shown in Fig. 5 , a dose of 10 ng of microinjected enzyme (-200 nM intracellular concentration, assuming an uniform diffusion in the water volume of the oocyte) inhibits about 50% maturation. A similar result was obtained by using oocytes of 3 different females. The oocytes that did not resume meiosis remained apparently healthy during >10 hr following alkaline phosphatase and progesterone treatment as judged by the presence of a normal germinal vesicle observed after cytological analysis. This inhibition was dose dependent (Fig. 6) .
When alkaline phosphatase was microinjected 4 hr before progesterone treatment, the dose of enzyme necessary to inhibit 50% of maturation was decreased by one-half (Fig. 6 ). This result indicates that the in vivo action of the enzyme is time dependent. At higher concentration (25 ng), alkaline phosphatase totally blocked progesterone-induced maturation; however, in some cases, the migration of the germinal vesicle toward the animal pole was observed.
Alkaline phosphatase from E. coli was tested also at the same activity as calf intestine phosphatase (assayed at 20°C, A MPF-containing cytoplasmic extract was prepared in the absence of 2-glycerophosphate as described by Wasserman and Masui (16) . It was treated with alkaline phosphatase (5 ,uM) at 0C for 30 min and injected into oocytes. No maturation was observed. kaline phosphatase exist in the Xenopus oocyte? (iii) Is this phosphatase a protein phosphatase?
The in vivo function of alkaline phosphatase remains unknown [a wide variety of low molecular weight phosphate esters can serve, in vitro, as substrates (17)]; its activity is known to change dramatically during altered cell growth. It was recently reported that an alkaline phosphatase, at low concentrations (50 nM) apd neutral pH, dephosphorylates in vitro proteins containing phosphotyrosines (18) . Much higher concentrations of this alkaline phosphatase are needed to dephosphorylate phosphoserine or phosphothreonine residues. Therefore, microinjected alkaline phosphatase might hydrolyze either low molecular weight phosphate esters present in the oocyte or phosphorylated proteins (or both).
The presence of free phosphorylated amino acids has not been reported in Xenopus oocytes, although their amino acid pool has been studied extensively (19) . The possibility that a free phospho amino acid plays a key role in the mechanism of maturation cannot be totally excluded. Recently, Fukami and Lipmann (20) reported that a high level of phosphotyrosine is present in Drosophila larvae and that a phosphotyrosine phosphatase controls its hydrolysis. We have, to date, no evidence supporting such a possibility in Xenopus oocytes.
The most logical and simple explanation of our findings is that alkaline phosphatase dephosphorylates one or more endogenous phosphoproteins of the Xenopus oocytes. If this assumption is correct, one may postulate that the putative endogenous protein(s) substrate of exogenous alkaline phosphatase must be maintained under its phosphorylated form during the phosphorylation cascade involved in the formation of MPF; this phosphorylated protein might be MPF itself. On the other hand, after microinjection, alkaline phosphatase is diluted inside the oocyte to a low concentration (0.1-0.2 ,uM) at physiological pH. Under these conditions, it may act as a phosphotyrosine protein phosphatase (18) .
The hypothesis that a phosphoprotein, perhaps a protein phosphorylated on tyrosine, is involved in MPF activity is reinforced by the phosphotyrosine and 2-glycerophosphate microinjection experiments (Fig. 4) . The simplest explanation of these findings is that all of the microinjected phosphoesters inhibit more or less completely the same endogenous phosphoprotein phosphatase. The inhibition of this phosphatase activity would be necessary to generate transferable MPF activity. Little is known about endogenous phosphoprotein phosphatases of the Xenopus oocyte. Brachet has reported the presence of an alkaline phosphatase in both the cytoplasm and germinal vesicle of Rana oocytes (21) . It was shown recently that 32P-labeled P-histones are dephosphorylated when microinjected into Xenopus oocytes (22) . This indicates the presence of active protein phosphatases in the living oocyte. However, these in vivo experiments do not provide information about the specificity of the phosphatase activities. Nevertheless, the phosphatase inhibited by 2-glycerophosphate and other phosphoesters can be distinguished from protein phosphatase 1. In fact, when protein phosphatase 1 is inhibited by the proteic inhibitor 1 or 2 (8, 9) , the formation of MPF and, consequently, the maturation are blocked, whereas 2-glycerophosphate facilitates maturation. Our results indicate that two different phosphatases are involved during oocyte maturation: (i) protein phosphatase 1, which dephosphorylates a putative maturation protein substrate of cAMP-dependent protein kinase (6, 7, 10) , and (ii) a phosphoprotein phosphatase with a substrate specificity similar to that of alkaline phosphatase at neutral pH. The hypothesis that it might be a phosphotyrosine phosphatase must be tested since we have found that proteins containing phosphotyrosine were present in the membranes of mature oocytes (unpublished results).
The present results raise an important technical point concerning the purification of MPF. In fact, we demonstrate in this article that all of the buffers used to prepare MPF, containing either 2-glycerophosphate or orthophosphate, interfere in ovo with the mechanism of MPF formation. Therefore, the claim for MPF enrichment would be more convincing if 2-glycerophosphate was omitted from the microinjection buffers. This does not mean that "purified" MPF does not contain active protein factor(s), as shown by dilution curves (2, 12, 23) , but these factors, when tested in the presence of 2-glycerophosphate, may only be related indirectly to MPF.
In conclusion, we have shown that purified alkaline phosphatase exhibits an in vivo biological activity; it probably acts as a phosphoprotein phosphatase to block the first meiotic cell division of the Xenopus oocyte. Our microinjection experiments have established that alkaline phosphatase inhibits both in vitro and in vivo MPF activity. MPF activity has been reported to be present not only in mature oocytes of vertebrates and invertebrates (1) but also to exist in the G2 M transition of cycling somatic cells (24) . The finding that exogenous alkaline phosphatase blocks nuclear envelope breakdown in Xenopus oocytes may be of general significance for the elucidation of an essential step in the cell cycle.
